ArticleAnnals of clinical and translational neurology2022

Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stages.

Roy Freeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.